Literature DB >> 35235581

Adherence to COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021: Community-based cross-sectional study.

Wubedle Zelalem Temesgan1, Mastewal Belayneh Aklil1, Henok Solomon Yacob2, Esubalew Tsega Mekonnen2, Elias Derso Tegegne2, Esubalew Binega Tesfa2, Eshetie Melkie Melese2, Tewodros Seyoum3.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) causes more than five million deaths worldwide. Pregnant women are at high risk for infection due to the physiologic change in the immune and cardiopulmonary system and also it increases the risk of severe disease, intensive care unit admission, and receive mechanical ventilation when compared with non-pregnant women. It is associated with adverse maternal and neonatal outcomes. So pregnant women need to have adhered to preventive measures to prevent COVID-19 related consequences. Therefore, this study aimed to assess adherence toCOVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia.
METHODS: A community-based cross-sectional study was conducted from July 1st to 30th, 2021, in Gondar city. A cluster sampling technique was employed to select 678 pregnant women. Data were collected using a pre-tested, face-to-face interviewer-administered questionnaire. Data were entered into EPI DATA version 4.6 and exported to SPSS version 25 for analysis. Both bivariable and multivariable logistic regression analysis was fitted to identify associated factors. Adjusted odds ratio with a 95% confidence interval was used to report the association between covariates and the outcome variable.
RESULTS: The prevalence of good adherence to COVID-19 preventive practice was 44.8% (95% CI: 41.3, 48.7). Maternal age (≤24 years) [AOR = 2.89, 95% CI: 1.37, 6.10], maternal education (secondary school) [AOR = 2.95, 95% CI: 1.58, 5.53] and (college and above) [AOR = 4.57,95% CI: 2.42, 8.62], having ANC follow up [AOR = 2.95, 95% CI: 1.35, 6.46] and adequate knowledge towards COVID-19 [AOR = 1.70, 95% CI: 1.20, 2.41] were significantly associated with good adherence to COVID-19 preventive practice.
CONCLUSION: In this study, adherence towards COVID-19 preventive practice in pregnant women is low. Hence, it is important to strengthen women's awareness about COVID-19 through different media and health education. In addition, empowering women to attain ANC and special consideration should be given to women who had no formal education.

Entities:  

Mesh:

Year:  2022        PMID: 35235581      PMCID: PMC8890631          DOI: 10.1371/journal.pone.0264237

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Coronavirus disease 2019 (COVID-19) is a novel virus that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first detected at the end of December 2019, in Wuhan city China [1, 2]. As COVID-19 rapidly distribute throughout the world, World Health Organization (WHO) declared it as a public health emergency of international concern on January 30, 2020 [3]. Following this, due to the continuous rise of COVID-19 related cases and deaths, WHO declared the disease a global pandemic on, March 11, 2020 [4-6]. The Ethiopian government announced the first case was detected on March 13, 2020 [7]. Currently, from the total population of Ethiopia (116.4 million), more than four million people screened for COVID-19 and more than six thousand deaths are recorded [8, 9]. Globally, COVID-19 had spread to over 219 countries and has influenced different devastating problems to the human race including mortality and morbidity, and social and economic crisis [7, 10]. As November 20, 2021 report, confirmed COVID-19 cases were 257,123,909, deaths 5,158,990 and 232,181,236 cases were recovered from COVID-19 in the world, and 8,654,048 cases, 221,941 deaths and 8,035,451 cases were recovered from COVID-19 in Africa and 369,867 cases, 6,662 deaths and 346,547 recovery were recorded in Ethiopia [11]. The presence of different COVID-19 variants (Delta, Kappa, Alpha, Beta etc.), with high mutation characteristics and ineffectiveness of the vaccine makes the pandemic difficult to control in the world. This virus variation possibly creates more worst complications in the third wave of the pandemic [12]. World Health Organization (WHO) has recommended several preventive measures to curve down the spread of the disease like regular handwashing with water and soap, social distancing, wearing mask, covering the mouth while coughing and sneezing, avoiding touching eyes, nose, and mouth [13]. In addition, scholars showed that consumption of fiber rich foods and micronutrients can boost immunity and prevent adverse pregnancy outcomes in COVID-19 infected women [14, 15]. The government of Ethiopia has also engaged in different activities to halt the spread of the virus in the country like Community mobilization, public awareness creation, isolation, compulsory quarantine, and treatment, strict passenger screening, house to house screening, and scaling up diagnostic tests and treatment centers [16]. Every person is at risk of becoming infected with COVID-19. However, pregnant women are at high risk for infection because the physiologic change in the immune and cardiopulmonary system during pregnancy makes them more susceptible to SARS-CoV-2 infection when compared to the general population [17, 18]. Centre for Disease Control and Prevention (CDC) report showed that pregnant women with COVID-19 infection are at increased risk of severe disease, intensive care unit admission, and receiving mechanical ventilation when compared to non-pregnant patients [17, 19, 20]. Moreover, it is associated with maternal and neonatal complications like miscarriage, preterm births, intrauterine growth restriction, fetal distress, and preeclampsia [17, 21, 22]. A study showed that COVID -19 can pass directly from mother to fetus during pregnancy [23]. There is also evidence that revealed that during the pandemic the risk of perinatal anxiety, depression, and domestic violence also increase in pregnant women [24]. Even though pregnant women have not been included in any COVID-19 vaccine clinical trials, the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine recommend that pregnant women can take COVID-19 vaccines if they prefer to be vaccinated [25-27]. Although the spread of COVID -19 increases every day in Ethiopia, the vaccine is not accessible for pregnant women. so pregnant women need to have adhered to preventive measures set by the Ministry of Health (MoH) to decrease the likelihood of being infected by the virus. This reduces maternal and neonatal morbidity and mortality. In Ethiopia, researches addressing the highly vulnerable pregnant women are scarce, particularly in the study area. Therefore, this study aimed to assess adherence with COVID-19 preventive practice and associated factor among pregnant women in Gondar city, northwest Ethiopia.

Methods and materials

Study design and setting

A community-based cross-sectional study was conducted in Gondar city from July 1st to 30th, 2021. Gondar city is located 166 km far from Bahirdar, the capital city of Amhara regional state, and 750 km northwest of Addis Ababa, the capital city of Ethiopia. According to the Population projection of Ethiopia for all regions at the woreda level from 2014–2017, the total population of the town was estimated to be 306,246. Among these, 156,276 of the population are females [28]. Currently, it has 1 governmental comprehensive specialized hospital, 8 governmental health centers, 22 health posts, 1 private primary hospital, and 1 general hospital serving the population of the city and catchment area.

Study population and eligibility criteria

The study population were all pregnant women in the selected clusters of Gondar city during the data collection period and residing in the study area for at least six months before the data collection period.

Sample size determination and sampling procedure

The sample size was determined by using a single population proportion formula by considering a proportion of good practice 47.6% [29], level of confidence 95%, margin of error 5%. Thus, the sample size . After considering a design effect of 1.5, and a non-response rate of 10%, the total sample size was 634. Gondar city has 22 kebeles (the smallest administrative unit in Ethiopia) and five kebeles were selected by a lottery method. All eligible participants in the selected cluster were included in the study, making the final sample size of 678.

Variables of the study

Adherence with COVID-19 preventive practice was the outcome variable whereas, maternal age, religion, maternal educational status, maternal occupation, marital status, husband educational status, husband occupation, number of families living together, average monthly income, gravidity, number of alive children, having ANC visit, number of ANC visit, condition of pregnancy, history of previous adverse pregnancy outcome, history of chronic illness and knowledge about COVID- 19 preventive practice were independent variable of the study.

Operational definitions and measurements

Adherence to COVID-19 preventive practice

It was measured by using 6 item questions derived from WHO recommendation on prevention measures against COVID -19 and participants were asked to answer their practice in the last 14 days. Each correct response weighed 1 point and 0 for an incorrect response. Participants who scored 100% on the practice of COVID-19 preventive measures were considered as having good adherence to COVID- 19 preventive practice. Whereas, participants who scored < 100% were considered as having poor adherence to COVID- 19 preventive practice [30, 31].

Knowledge

It was measured by using 14 item questions that include clinical presentation, risk factors, prognosis, and prevention measures of COVID-19. Each correct response weighed 1 point and 0 for an incorrect response. Participants who scored ≥65% of knowledge questions were considered as having adequate knowledge and those who scored < 65% were considered as having inadequate knowledge [31].

Data collection tools & procedures

The data collection tool was developed by reviewing related literature [29, 31–33]. Data were collected using semi-structured, pretested questionnaires through a face-to-face interview. The questionnaire contains socio-demographic characteristics, obstetric-related variables, and knowledge and preventive practice of COVID-19 related questions. Five BSc midwives and one MSc clinical midwife were recruited for data collection and supervision respectively.

Data quality control measures

The questionnaire was prepared in English and then translated into the local language Amharic with the assistance of language experts then translated back to English to maintain consistency of the tool. Before the actual data collection, the questionnaire was pretested on 5% of the total sample size at Kola Diba district to check the response, language clarity, and appropriateness of the questionnaire. One-day training was given for data collectors and supervisor about the aim of the study, contents of the tool, and techniques of data collection. In addition, the data collectors and supervisor were informed regarding important precautions to be taken to prevent COVID-19 infection. During data collection, data collectors were supervised for any difficulties. The consistency and completeness of the data were checked by the data collectors and supervisor and the incomplete data were discarded before data entry.

Data processing & analysis

The data were checked, coded, and entered into Epi data version 4.6 and then exported to SPSS version 25 for analysis. Descriptive statistics like frequencies, percentages, mean and standard deviation were computed. Bivariable logistic regression was done to identify the association between independent and dependent variables, variables with p-values less than 0.2 were entered into multivariable logistic regression analysis. Adjusted odds ratio with 95% CI was used to determine the level of significance at p-value of ≤ 0.05.

Ethical consideration

Ethical clearance was obtained from the University of Gondar ethical review committee. A supportive letter was obtained from selected kebeles administrates. Written informed consent was taken from each study participant after a clear explanation of the aim of the study. Study participants were also informed that they had the full right to withdraw from the interview at any time.

Results

Socio-demographic characteristics of study participants

In this study, a total of 663 women were included in the analysis making a response rate of 97.8%. The age of the participants ranges from19 to 44 years with a mean age of 31.25 (±5.525 SD) years. More than half (57.5%) of the respondents were in the age group of 25–34 years. Nearly two-thirds (66.4%) of study participants were Orthodox Christians in religion. The majority (94%) of the study participants were married. Regarding husband’s educational status nearly one-third (31.5%) of their husband had attended secondary school (Table 1).
Table 1

Sociodemographic characteristics of pregnant women in Gondar city, northwest Ethiopia 2021 (n = 663).

VariablesFrequencyPercent (%)
Maternal age
≤24 years436.5
25–34 years38157.5
≥35 years23936.0
Religion
Orthodox44066.4
Muslim17826.8
Protestant416.2
Catholic40.6
Maternal educational status
Unable to read and write7110.7
Able to read and write16024.1
Elementary(1–8)10616.0
Secondary School(9–12)16725.2
College and above15924.0
Maternal occupation
Housewife27341.2
Civil servant17025.6
Private Business18628.1
Farmer142.1
Others*203.0
Marital status
Married62394.0
Unmarried406.0
Husband educational status (n = 623)
Unable to read and write335.3
Able to read and write17427.9
Elementary(1–8)518.2
Secondary School(9–12)19631.5
College and above16927.1
Husband occupation (n = 623)
Civil servant20933.5
Private Business35256.5
Farmer569.0
Others**61.0
Number of family living together
≤210616.0
3–430045.2
≥525738.8
Average monthly income
<5000 ETB17726.7
5000–10000 ETB32348.7
>10000 ETB16324.6

Others*; daily laborer and student, Others**; daily laborer and unemployed, ETB; Ethiopian birr

Others*; daily laborer and student, Others**; daily laborer and unemployed, ETB; Ethiopian birr

Obstetric and reproductive characteristics of study participants

Among the total study participants, more than three-fourths (79.2%) and the majority (93.4%) of them were multigravida in their gravidity and had antenatal care (ANC) follow up respectively. Regarding the condition of pregnancy 601 (90.6%) of the pregnancy was planned (Table 2).
Table 2

Obstetric and reproductive characteristics of pregnant women in Gondar city, northwest Ethiopia, 2021 (n = 663).

VariablesFrequencyPercent (%)
Gravidity
Primigravida13420.8
Multigravida52979.2
Number of alive children
No alive children14121.3
<334552.0
≥317726.7
ANC follow up
Yes61993.4
No446.6
Number of ANC follow up (n = 619)
≤344471.7
>317528.3
Condition of pregnancy
Planned60190.6
Unplanned629.4
History of previous adverse pregnancy outcome
Yes12118.3
No54281.7
History of chronic illness
Yes13219.9
No53180.1

Knowledge about COVID-19

From the total study participants, 422 (63.7%) had adequate knowledge about COVID-19. Almost all respondents heard about COVID-19. More than half (52.3%) and (53.5%) of pregnant women said that sore throat and runny nose are a symptom of COVID-19 respectively. Five hundred twenty-seven (79.48%) respondents know that pregnant women have higher risk for COVID-19 than other populations (Table 3).
Table 3

Knowledge of pregnant women about COVID-19 in Gondar city, northwest Ethiopia 2021 (n = 663).

Knowledge itemCorrect response n (%)Incorrect response n (%)
Ever heard about COVID-19660 (99.5)3 (0.5)
COVID-19 is viral disease561 (84.6)102 (15.4)
Respiratory droplets and close contact are the main transmission route.578 (87.2)85 (12.8)
All people are generally susceptible to COVID-19459 (69.2)204 (30.8)
Dry cough is a symptom of COVID-19521 (78.6)142 (21.4)
Fever is a symptom of COVID-19405 (61.1)258 (38.9)
Headache is a symptom of COVID-19502 (75.7)161 (24.3)
Sore throat is a symptom of COVID-19347 (52.3)316 (47.7)
Runny nose is a symptom of COVID-19355 (53.5)308 (46.5)
Difficulty of breathing is a symptom of COVID-19557 (84.0)106 (16.0)
Stay at home and wearing face mask can prevent COVID-19630 (95.0)33 (5.0)
People with co-existing disease has poor prognostic outcome427 (64.4)236 (35.6)
Person with COVID-19 can transmit the virus to others without developing sign437 (65.9)226 (34.1)
Pregnant women are at high risk than others527 (79.5)136 (20.5)

Adherence to COVID-19 preventive practice

The finding of this study showed that only 44.8% (95% CI: 41.3, 48.7) of the participants had good adherence to COVID-19 preventive practice (Fig 1). About three-fourths (74.1%) and majority (90.3%) of participants wash hands with water and soap or with alcohol-based sanitizer and wear a face mask in public to decrease the spread of infection respectively (Fig 2).
Fig 1

Adherence with COVID-19 preventive practice among pregnant women in Gondar city, northwest Ethiopia, 2021.

Fig 2

Adherence to specific COVID-19 preventive practice among pregnant women in Gondar city, northwest Ethiopia, 2021.

Factors affecting adherence to COVID-19 preventive practice

In the bi-variable analysis: maternal age, maternal educational status, marital status, number of families living together, average monthly income, gravidity, number of alive children, ANC follow up and knowledge about COVID-19 were significantly associated with COVID-19 preventive practice adherence at a p-value <0.2. Of these variables: maternal age, maternal educational status, ANC follow up and knowledge about COVID-19 were statistically significant to adherence with COVID-19 preventive practice in multivariable logistic regression. Study participants whose age ≤ 24 years were 2.89 times more likely to have good adherence to COVID-19 preventive practice as compared to participants whose age group of ≥35 years [AOR = 2.89, 95% CI: 1.37, 6.10]. Respondents who had an educational level of secondary school and college and above were 2.95, and 4.57 times more likely to have good adherence to COVID-19 preventive practice as compared to women who can not read and write respectively [AOR = 2.95, 95% CI: 1.58, 5.53], [AOR = 4.57, 95% CI: 2.42, 8.62]. The odds of good adherence with COVID-19 preventive practice were 2.95 times higher among women who had ANC follow-up as compared to their counterparts [AOR = 2.95, 95% CI: 1.35, 6.46]. Pregnant women who had adequate knowledge about COVID-19 were 1.7 times more likely to adhere to COVID-19 preventive practice than pregnant women who had inadequate knowledge about COVID-19 [AOR = 1.70, 95% CI: 1.20, 2.41] (Table 4).
Table 4

Bivariable and multivariable logistic regression analysis of factors affecting adherence to COVID 19 preventive practice among pregnant women in Gondar city, northwest Ethiopia, 2021 (n = 663).

VariablesAdherenceCOR (95%CI)AOR (95% CI)
Goodpoor
Maternal age
≤2428152.73 (1.39, 5.38) 2.89 (1.37, 6.10) *
25–341722091.20 (0.87, 1.67)1.05 (0.74, 1.52)
≥359714211
Maternal educational status
Unable to read and write195211
Able to read and write451151.07 (0.57, 2.01)0.93 (0.53, 1.89)
Elementary(1–8)38681.53 (0.79, 2.95)1.36 (0.68, 2.71)
Secondary School(9–12)91763.28 (1.78, 6.01) 2.95 (1.58, 5.53) *
College and above104555.17 (2.79, 9.61) 4.57 (2.42, 8.62) **
Marital status
Married2723510.46 (0.24, 0.90)0.56 (0.27, 1.16)
Unmarried251511
Number of family living together
≤256501.82 (1.15, 2.87)0.58 (0.24, 1.39)
3–41431571.48 (1.05, 2.07)0.76 (0.45, 1.30)
≥59815911
Average monthly income
<50006711011
5000–100001421811.29 (0.88, 1.87)0.98 (0.65, 1.48)
>1000088751.93 (1.25, 2.97)1.48 (0.91, 2.41)
Gravidity
Primigravida74601.69 (1.15, 2.48)1.42 (0.23, 8.85)
Multigravida22330611
Number of alive children
No alive children77642.35 (1.49,3.70)1.47 (0.79, 2.71)
<31601851.69 (1.16, 2.46)1.26 (0.80, 1.98)
≥36011711
ANC follow up
Yes2873322.94 (1.43, 6.05) 2.95 (1.35, 6.46) *
No103411
Knowledge about COVID-19
Adequate knowledge2082141.66 (1.20, 2.29) 1.70 (1.20, 2.41) *
Inadequate knowledge8915211

COR-crude odds ratio, AOR-adjusted odds ratio, CI-confidence interval, 1-reference category,

*p≤0.05,

** p <0.01

COR-crude odds ratio, AOR-adjusted odds ratio, CI-confidence interval, 1-reference category, *p≤0.05, ** p <0.01

Discussion

This study has attempted to assess adherence with COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021. The study result showed that only 44.8% (95% CI: 41.3, 48.7) of the study participants had good adherence with COVID-19 preventive practice. These results are comparable with studies conducted in Ghana 46.6% [32], Egypt 42.86% [34], Wollega zone, Ethiopia 43.6% [33], and Debre Tabor, Ethiopia 47.6% [29]. This finding is lower than studies conducted in Nigeria 79.2% [35] and studies done in some parts of Ethiopia such as Gurage zone, 76.2% [31], Debre Berhan, 56.1% [36]. The possible reason for this discrepancy could be due to the difference in the study setting, variation in measuring outcome variable, and sociodemographic characteristics of the study participants. All the above-mentioned studies were institution-based cross-sectional studies. Women who came for ANC follow-up can get information about COVID-19 and are highly likely to practice it. Studies in Nigeria and Debre Berhan used mean score and 80% as a cut of point to say participants had good adherence respectively. Whereas, in this study, 100% was used as a cut of point to measure the outcome variable. In addition, 91% and 87.2% of study participants in Nigeria attained at least primary education and had good knowledge of COVID-19 infections respectively. However, in this study, more than one-third (34.8%) of pregnant women had no formal education and 63.7% had adequate knowledge about COVID-19. However, the result of this study is higher than the study in Ebonyi, state, Nigeria 30.3% [37]. The possible explanation for the discrepancy might be due to differences in the time gap of the study and study setting. As time goes community awareness creation and Information dissemination strategies also improved and it might have a positive impact on preventive practice. In addition, 39.1% of study participants in Ebonyi, state were rural dwellers while this study was conducted on urban residents. It has been evidenced that pregnant women living in urban areas were highly likely to practice preventive measures [32, 33]. In this study, maternal age is one of the variables significantly associated with good adherence to COVID-19 preventive practice. Study participants whose age ≤24 years were 2.89 times more likely to have good adherence with COVID -19 preventive practice as compared to participants whose age was≥35 years. This finding was supported by a study conducted in Nigeria [35] and studies in different parts of Ethiopia, Wollega zones, [33], Gurage zone, [31]. This might be due to younger women having access to information on COVID-19 (risk, mode of transmission, and way of preventive measures) via social media and mass media. Also, it might be younger women have better educational attainment than older women. Pregnant women who had a higher level of education have good adherence with COVID -19 preventive practice. On the contrary, studies conducted in Ghana [32] and Debre Berhan, Ethiopia [36], as age increase the odd of good preventive practice also increase. The study also revealed that women with educational level of secondary school and, college and above were 2.95 and 4.57 times more likely to have good adherence with COVID-19 preventive practice as compared to women’s who cannot able to read and write respectively. This finding was supported by studies conducted in Ghana [32], Debre Tabor, Ethiopia [29]. This might be due to the fact that educated people can access information about COVID -9 including its prevention method from different sources than those unable to read and write. In addition, educated people might have a better understanding of preventive measures and consequences associated with not doing this preventive practice. ANC follow up also one of the important predictors of good adherence to COVID-19 preventive practice. The odds of good adherence with COVID-19 preventive practice were 2.95 times higher among women who had ANC follow-up as compared to their counterparts. This might be pregnant women who had ANC follow-up have a chance to get information about the pandemic from the health care providers during their visit. Study showed that obtaining COVID-19 education at a health facility was significantly associated with adequate knowledge on COVID-19 prevention [32]. This study also showed that there was a significant association between the knowledge of the respondents and adherence to COVID-19 preventive practice. Pregnant women who had adequate knowledge about COVID-19 were 1.7 times more likely to adhere to COVID-19 preventive practice than pregnant women who had inadequate knowledge about COVID-19. This finding was supported by studies conducted in Debre Berhan [36] and Debre Tabor, Ethiopia [29]. This might be due to women who had prior knowledge about the pandemic including the benefits of preventive measures may apply it to protect themselves and their families against the pandemic.

Limitation of the study

The cross-sectional nature of the study design might not possible to infer the cause and effect relationship between pregnant women’s adherence with COVID-19 preventive practice and its associated factors. There might be also a social desirability bias.

Conclusion

In this study, adherence with COVID-19 preventive practice among pregnant women is low. Maternal age, maternal occupational status, ANC follow up and knowledge about COVID-19 were factors affecting adherence with COVID-19 preventive practice. Therefore, it is important to strengthen the health education of pregnant women about COVID-19 preventive practice through different media. In addition, empowering women to attain ANC and special consideration should be given to women who had no formal education.

English version questionnaire.

(DOCX) Click here for additional data file. (SAV) Click here for additional data file. 25 Jan 2022
PONE-D-21-40668
Adherence with COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021: Community based cross -sectional study
PLOS ONE Dear Dr. Temesgan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sanjay Kumar Singh Patel, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Thank you for stating the following financial disclosure: [No fund was received for this work]. At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ. 4. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. 5.  Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I think that it is very important to study the adherence to the preventive protocols, mainly for pregnants in Africa. I would recommend to correctly call a model with only one explanatory variable as simple logistic regression model. A model with more than one explanatory variable is a multiple logistic regression model. It is wrong to call as bivariable (or bivariate) and multivariable or multivariable. I proposed few minor corrections in the .pdf appended file. Reviewer #2: In this paper entitled "Adherence with COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021: Community-based cross-sectional study", the authors investigated the obedience with COVID-19 preventive practices and associated factors among pregnant women. This study is unique because it selected 678 pregnant women during the community-based cross-sectional survey and analyzed the data with rigorous statistics. Moreover, pregnant women are at risk during the pandemic due to physiological reasons. Also, pregnant women are generally excluded from any COVID research and not given vaccines. So this study provided a glimpse of how COVID-19 preventive practices are practiced by pregnant women in Gondar City, North Ethiopia. The manuscript is fascinating and easy to understand. However, there are a few problems in the manuscript. Minor Comments: 1) A cross-sectional survey of 678 pregnant women in Gondar city can't corroborate the practice practiced by Ethiopia's whole pregnant women population. Mention this in the limitation of the study section. 2) Introduction: The authors should provide information like mortality rate, incubation, various initial prevention approaches, and diet and natural biomolecules for improving immunity and health (doi: 10.1007/s12088-020-00908-0). 3) In the introduction, minor information on the variants of COVID-19 and their future challenges can be included i.e. doi: 10.1007/s15010-021-01734-2. 3) At least one additional Figure (illustration) may be provided to highlight this study's summary or prospect. Reviewer #3: The manuscript is well written, and it can be accepted after the minor revision. Please find my comments below. 1. Please provide some information on the effect of diet to boost the immunity of pregnant woman towards the treatment of Covid-19 and their variant in the discussion section and the following paper may be followed and cited; Indian Journal of Microbiology, 2020, volume 60, pages 420–429. 2. I would recommend few more figure to describe your explanations instead of tables. ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
Submitted filename: PONE-D-21-40668_reviewer.pdf.pdf Click here for additional data file. 31 Jan 2022 Response to Reviewers Date: 31/1/2022 PLOSS ONE Manuscript number: PONE-D- 21-40668 We would like to say thank you for giving us the opportunity to submit a revised draft of our manuscript titled “Adherence with COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021: Community-based cross-sectional study”. We appreciate the time and effort that you have dedicated to provide your valuable feedback on our manuscript. We are grateful to the entire editorial team and peer reviewers for their insightful comments on our paper. We have been able to incorporate changes to reflect most of the suggestions provided by the reviewer. Here is a point-by-point response to specific comments and concerns. Academic Editor’s comments and concerns 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. Response: Thank you, dear editor, we kindly accepted your request and we did that in the revised manuscript. 2. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Response: Thank you, dear editor, we kindly accepted your request and we have corrected in the revised manuscript as “the authors received no specific funding for this work”. Please see the tack change in the revised manuscript. 3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. Response: Thank you for pointing this out, I have already created an ORCID id 4. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available Response: Thank you very much. We have uploaded the minimal data set as supporting information when we submitted the manuscript. If it is necessary, we have uploaded it again as S1 English version questionnaire and S1 Dataset. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Response: Thank you, dear editor, we kindly accepted your request and we have checked all listed references and all are complete, correct and there is no retracted paper. Reviewer #1 1.I would recommend to correctly call a model with only one explanatory variable as simple logistic regression model. A model with more than one explanatory variable is a multiple logistic regression model. It is wrong to call as bivariable (or bivariate) and multivariable or multivariable. Response: Thank you, dear reviewer, for your thoughtful concern. As we tried to review evidence, a multiple or multivariable logistic regression model is a model with more than one explanatory variable with a single binary outcome and we can use interchangeably. However, multivariate implies a statistical analysis with multiple outcomes. Please kindly visit the following articles: 1: Distinction between Two Statistical Terms: Multivariable and Multivariate Logistic Regression: doi:10.1093/ntr/ntaa055. 2: Multivariable Analysis in Cerebrovascular Research: Practical Notes for the Clinician: DOI: 10.1159/000345491 2.I proposed few minor corrections in the .pdf appended file. Response: Thank you, as per your kind recommendation, we tried to correct in the revised manuscript. Please kindly see the track changes. Reviewer#2 MinorComments: 1) A cross-sectional survey of 678 pregnant women in Gondar city can't corroborate the practice practiced by Ethiopia's whole pregnant women population. Mention this in the limitation of the studysection. Response: Thank you, dear reviewer, for your thoughtful concern. We knew that the limitations of the study are those characteristics of design or methodology that impacted or influenced the application or interpretation of the results of the study. Our study finding is generalized to the source population (all pregnant women in Gondar city). But, it is not generalized to Ethiopia's whole pregnant women population. So this not our study limitation. 2) Introduction: The authors should provide information like mortality rate, incubation, various initial prevention approaches, and diet and natural biomolecules for improving immunity and health (doi: 10.1007/s12088-020-00908-0). Response: The authors would like to thank you for your constructive and helpful feedback. Comment accepted and corrected accordingly. Please kindly see the revised version. 3) In the introduction, minor information on the variants of COVID-19 and their future challenges can be included i.e. doi: 10.1007/s15010-021-01734-2. Response: Thank you for your constructive and helpful feedback. Comment accepted and corrected accordingly. please kindly see the track change. 3) At least one additional Figure (illustration) may be provided to highlight this study's summary or prospect. Response: Thank you for your suggestion. We have agreed with your suggestion and corrected in the revised manuscript. Please kindly see the revised manuscript. Reviewer #3: 1. Please provide some information on the effect of diet to boost the immunity of pregnant woman towards the treatment of Covid-19 and their variant in the discussion section and the following paper may be followed and cited; Indian Journal of Microbiology, 2020, volume 60, pages 420–429. Response: Thank you for your constructive and helpful feedback. Comment accepted and we incorporate it in the introduction section by considering it is the ideal section . Please kindly see the track change. 2. I would recommend few more figure to describe your explanations instead of tables. Response: Thank you, dear reviewer, we have amended it accordingly. Please kindly see the revised manuscript. Best regards! Wubedle Zelalem Temesgan Submitted filename: Response to Reviewers.docx Click here for additional data file. 7 Feb 2022 Adherence to COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021: Community-based cross-sectional study PONE-D-21-40668R1 Dear Dr. Temesgan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sanjay Kumar Singh Patel, Ph.D. Academic Editor PLOS ONE 11 Feb 2022 PONE-D-21-40668R1 Adherence to COVID-19 preventive practice and associated factors among pregnant women in Gondar city, northwest Ethiopia, 2021: Community-based cross-sectional study Dear Dr. Temesgan: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sanjay Kumar Singh Patel Academic Editor PLOS ONE
  22 in total

Review 1.  Coronavirus in pregnancy and delivery: rapid review.

Authors:  E Mullins; D Evans; R M Viner; P O'Brien; E Morris
Journal:  Ultrasound Obstet Gynecol       Date:  2020-05       Impact factor: 7.299

2.  Knowledge and practice to prevent COVID-19 and its associated factors among pregnant women in Debre Tabor Town Northwest Ethiopia, a community-based cross-sectional study.

Authors:  Alemu Degu Ayele; Gedefaye Nibret Mihretie; Habtamu Gebrehana Belay; Adanech Getie Teffera; Bekalu Getnet Kassa; Bedemariam Tadesse Amsalu
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-21       Impact factor: 3.007

3.  Assessment of Knowledge, Attitudes, and Perception of Health Care Workers Regarding COVID-19, A Cross-Sectional Study from Egypt.

Authors:  Wafaa Yousif Abdel Wahed; Enas Mamdouh Hefzy; Mona Ibrahim Ahmed; Nashwa Sayed Hamed
Journal:  J Community Health       Date:  2020-12

4.  Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020.

Authors:  Sascha Ellington; Penelope Strid; Van T Tong; Kate Woodworth; Romeo R Galang; Laura D Zambrano; John Nahabedian; Kayla Anderson; Suzanne M Gilboa
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-26       Impact factor: 17.586

5.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

Review 6.  Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.

Authors:  Xiaoxuan Zhao; Yuepeng Jiang; Yang Zhao; Hongyan Xi; Chang Liu; Fan Qu; Xiaoling Feng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-23       Impact factor: 3.267

Review 7.  Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.

Authors:  Sonja A Rasmussen; John C Smulian; John A Lednicky; Tony S Wen; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2020-02-24       Impact factor: 8.661

Review 8.  Diet, Gut Microbiota and COVID-19.

Authors:  Praveen Rishi; Khemraj Thakur; Shania Vij; Lavanya Rishi; Aagamjit Singh; Indu Pal Kaur; Sanjay K S Patel; Jung-Kul Lee; Vipin C Kalia
Journal:  Indian J Microbiol       Date:  2020-09-28       Impact factor: 2.461

9.  COVID-19 Preventive Measure Practices and Knowledge of Pregnant Women in Guraghe Zone Hospitals.

Authors:  Yohannes Fikadu; Alex Yeshaneh; Tamirat Melis; Molalegn Mesele; Walellign Anmut; Muche Argaw
Journal:  Int J Womens Health       Date:  2021-01-07
View more
  2 in total

1.  A Mixed-Methods Study of COVID-19 Vaccine Acceptance and Its Determinants Among Pregnant Women in Northeast Ethiopia.

Authors:  Zenebe Tefera; Mandefro Assefaw
Journal:  Patient Prefer Adherence       Date:  2022-08-23       Impact factor: 2.314

2.  Adherence to COVID-19 preventive measures and associated factors in Ethiopia: A systematic review and meta-analysis.

Authors:  Gdiom Gebreheat; Ruth Paterson; Henok Mulugeta; Hirut Teame
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.